284 related articles for article (PubMed ID: 26365556)
1. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
2. Prodifferentiation Activity of Novel Vitamin D₂ Analogs PRI-1916 and PRI-1917 and Their Combinations with a Plant Polyphenol in Acute Myeloid Leukemia Cells.
Nachliely M; Sharony E; Bolla NR; Kutner A; Danilenko M
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399677
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
4. Structure-function analysis of vitamin D(2) analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation.
Baurska H; Klopot A; Kielbinski M; Chrobak A; Wijas E; Kutner A; Marcinkowska E
J Steroid Biochem Mol Biol; 2011 Aug; 126(1-2):46-54. PubMed ID: 21550403
[TBL] [Abstract][Full Text] [Related]
5. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
Danilenko M; Wang X; Studzinski GP
J Natl Cancer Inst; 2001 Aug; 93(16):1224-33. PubMed ID: 11504768
[TBL] [Abstract][Full Text] [Related]
6. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
7. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
10. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of differentiation induction of HL-60 cells by 1,25-dihydroxyvitamin D3 in combination with carnosic acid].
Ren LH; Chen JJ; An HP
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):55-9. PubMed ID: 18289473
[TBL] [Abstract][Full Text] [Related]
12. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
[TBL] [Abstract][Full Text] [Related]
13. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of new vitamin D
Corcoran A; Bermudez MA; Seoane S; Perez-Fernandez R; Krupa M; Pietraszek A; Chodyński M; Kutner A; Brown G; Marcinkowska E
J Steroid Biochem Mol Biol; 2016 Nov; 164():66-71. PubMed ID: 26429396
[TBL] [Abstract][Full Text] [Related]
15. Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D₂ as Potential Anti-Leukemic Agents.
Corcoran A; Nadkarni S; Yasuda K; Sakaki T; Brown G; Kutner A; Marcinkowska E
Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26840307
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
18. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.
Sharabani H; Izumchenko E; Wang Q; Kreinin R; Steiner M; Barvish Z; Kafka M; Sharoni Y; Levy J; Uskokovic M; Studzinski GP; Danilenko M
Int J Cancer; 2006 Jun; 118(12):3012-21. PubMed ID: 16395705
[TBL] [Abstract][Full Text] [Related]
19. Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3.
Takahashi H; Hatta Y; Iriyama N; Hasegawa Y; Uchida H; Nakagawa M; Makishima M; Takeuchi J; Takei M
PLoS One; 2014; 9(11):e113722. PubMed ID: 25409436
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.
Shabtay A; Sharabani H; Barvish Z; Kafka M; Amichay D; Levy J; Sharoni Y; Uskokovic MR; Studzinski GP; Danilenko M
Oncology; 2008; 75(3-4):203-14. PubMed ID: 18852491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
